Tag: Mylan

European Medical Agency to Review Biocon’s Anti Cancer Biosimilar Trastuzumab
Analysis, Global

European Medical Agency to Review Biocon’s Anti Cancer Biosimilar Trastuzumab

SMEStreet Desk- August 26, 2016

European Medicines Agency (EMA) has accepted for review Mylan's application to market biosimilar Trastuzumab, co-developed with Biocon, that is used to treat certain breast and gastric ... Read More